PDL BioPharma, Inc.

Historical 13F Holders

Symbol
PDLI
CUSIP
69329Y104
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 69329Y104 since 12/18/2024, largest first.

Filer % of Class Filed
Brandes Investment Partners, LP 13G 6.2% 8/13/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 4 42.5 k $1.51k
2026 Q2 6 54.4 k $29.2k
2026 Q1 7 54.5 k $29.2k
2025 Q4 9 183 k $28.0k
2025 Q3 8 190 k $28.0k
2025 Q2 7 182 k $28.0k
2025 Q1 7 182 k $28.0k
2024 Q4 7 182 k $28.0k
2024 Q3 5 182 k $28.0k
2024 Q2 7 187 k $28.0k
2024 Q1 7 187 k $28.0k
2023 Q4 6 187 k $130k
2023 Q3 6 187 k $130k
2023 Q2 7 187 k $130k
2023 Q1 4 186 k $26.5k
2022 Q4 4 190 k $0
2022 Q3 3 190 k $0
2022 Q2 3 190 k $0
2022 Q1 6 202 k $27.0k
2021 Q4 5 205 k $0
2021 Q3 8 15.0 M $41.1M
2021 Q2 8 15.3 M $37.9M
2021 Q1 11 14.9 M $36.7M
2020 Q4 33 42.1 M $107M
2020 Q3 133 98.4 M $311M
2020 Q2 137 95.6 M $280M
2020 Q1 134 91.3 M $665M
2019 Q4 152 98.1 M $318M
2019 Q3 142 99.3 M $215M
2019 Q2 148 106 M $334M
2019 Q1 158 116 M $437M
2018 Q4 154 120 M $347M
2018 Q3 154 126 M $331M
2018 Q2 163 128 M $300M
2018 Q1 177 135 M $397M
2017 Q4 188 141 M $387M
2017 Q3 187 138 M $467M
2017 Q2 173 130 M $322M
2017 Q1 177 134 M $304M
2016 Q4 193 130 M $276M
2016 Q3 199 130 M $435M
2016 Q2 203 126 M $395M
2016 Q1 197 127 M $424M
2015 Q4 206 135 M $478M
2015 Q3 215 139 M $715M
2015 Q2 204 147 M $946M
2015 Q1 214 144 M $1.02B
2014 Q4 223 159 M $1.23B
2014 Q3 232 152 M $1.14B
2014 Q2 224 144 M $1.40B
2014 Q1 234 141 M $1.17B